Enliven Therapeutics
ELVN
#5603
Rank
$0.87 B
Marketcap
$17.91
Share price
0.22%
Change (1 day)
-2.13%
Change (1 year)

Enliven Therapeutics (ELVN) - P/B ratio

P/B ratio as of April 2025 : 2.83

According to Enliven Therapeutics's latest financial reports the company has a price-to-book ratio of 0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Enliven Therapeutics - P/B ratio (from 2023 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-313.5352.08%
2023-12-312.32
2022-12-31N/A
2021-12-31N/A